Working with Boehringer Ingelheim, and the University of Plymouth, the AHSN Network has launched a new evidence-based guide to support digital health innovators and leaders to conduct meaningful patient and public involvement and engagement.

The new user-friendly guide, entitled ‘How to involve and engage patients in digital health tech innovation’ has combined the results of a systematic literature review, advisory panels and multi-stakeholder input to produce four clear principles (ENACT) around patient and public involvement and engagement (PPIE).

The principles make it clear how to involve patients in product innovation and make recommendations around critical issues such as data privacy, intellectual property, inclusivity, reimbursement, useability, and recruitment of patients for health technology entrepreneurs.

The guide not only helps with the initial digital development but also puts in place processes to support ongoing product improvement. By adopting the core principles, digital innovators can continually improve their product, better communicate its value to the system, and ultimately improve patient trust in the technologies created.

Commenting on the guide, Matt Whitty, Chief Executive of the Accelerated Access Collaborative and Director of Innovation, Research and Life Sciences, NHS England & NHS Improvement said: “Through research and innovation, we can improve patient outcomes and reduce health inequalities. Patient-centred digital technology is an increasingly important aspect of a dynamic and sustainable health system. By ensuring patients are involved in developing these digital technologies we will create solutions that best meet their needs. I hope this guide will help support innovative digital technology development across our health service.”

Richard Stubbs, Vice-Chair of the AHSN Network summarises why the guide is so valuable: “To drive true change in our healthcare system, a patient-centred approach must be at the heart. The guide makes key recommendations in this area. Simple steps such as building relationships with community leaders and influencers can help innovators engage with patients and families in under-represented demographics. I hope this guide can support inclusive innovation and make a positive impact in the digital transformation of the UK healthcare system.”

Uday Bose, Country Managing Director at Boehringer Ingelheim UK & Ireland, explains the importance of this guide: “Critical to the success of any efforts we undertake for patients is to engage and actively involve them from the start. Modern healthcare systems cannot deal with any wasted time or effort, so we hope that this guide helps the system to create patient-centric innovations in an efficient manner.”

The robust academic foundation for the guide was provided by the University of Plymouth’s research ‘Meaningful patient and public involvement in digital health innovation, implementation and evaluation: a systematic review’ which was recently published in the international journal Health Expectations’. The review was followed up by a Delphi study to consensually evolve the principles.

Professor Arunangsu Chatterjee, Dean of Digital Transformation, University of Leeds and Visiting Professor of Digital Health & Education at the University of Plymouth, said, “Digital health innovation is still fairly new territory and there is a need for clarity to ensure development that is inclusive of patients. Bringing together the academic rigour and expertise of organisations like ours, the commercial expertise of Boehringer Ingelheim and the community network of the AHSN has accelerated positive change, and the development of this resource has been a true partnership.”

The guide can be accessed via Boehringer Ingelheim’s website and will be distributed across the AHSN Network to support innovation across the NHS, helping to ensure patient voices are built into the digital reform of healthcare and is available for download here.

  • Collaborating to improve access and equity of care for sickle cell sufferers

    Harriet Smith is the Health Innovation Network's MTFM National Lead for Spectra Optia. In this blog, she outlines the collaborative efforts to improve the support available to people with sickle cell disease, and tackle long standing inequalities. Sickle cell disease (SCD) is a serious and lifelong health condition. People with SCD produce unusually shaped red [...]

  • Until tackling health inequalities becomes business as usual, innovation is our best chance of equity

    Dr Stuart Monk, National Programme Director for the Accelerated Access Collaborative (AAC) Programmes at the Health Innovation Network, talks about the pivotal role of innovation tackling healthcare inequalities in the NHS. At the Royal Society of Medicine’s Tackling Inequalities conference it was clear from the passion in the room that great progress has been made [...]

  • Where health innovation is concerned, 15 approaches are better than one

    Dr Phil Jennings, Vice Chair of the Health Innovation Network and Chief Executive of Health Innovation North West Coast, discusses why the Network’s collective relicensing gives innovation a better chance of success. In any one day in England, 1.2 million people attend a GP appointment, over a quarter of a million people have an outpatient [...]